Skip to content
Screener

Teladoc Health TDOC Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$642.3MBeat by $7.0M
EPS-$0.14Beat by $0.05
Revenue estimate$635.3M
EPS estimate-$0.19

Next report

Oct 28, 2026 (in a month)
Revenue estimate$590.3M
EPS estimate-$0.23

Financials

Q4 2025

Income statement

See full
Revenue$642.3M+0.3%
Gross profit$445.2M-1.4%
Operating income-$36.0M+25.3%
Net income-$25.1M+48.1%
EPS (diluted)-$0.14+46.2%

Balance sheet

See full
Cash & equivalents$781.1M-39.8%
Total debt$45.2M-92.4%
Total equity$1.4B-7.1%
Total assets$2.9B-18.7%

Cash flow

See full
Operating cash flow$87.7M+2.1%
CapEx$2.6M-57.3%
Free cash flow$85.1M+6.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.24B-20.6%
Enterprise value$506.47M-41.1%
P/S0.5×-0.1×

Profitability

See full
Gross margin69.5%-1.3pp
Operating margin-10.4%-4.4pp
Net margin-7.9%-3.5pp
FCF margin11.3%+0.3pp

Returns & leverage

See full
Return on equity-13.9%-5.9pp
Debt / equity0×-0.4×
Current ratio2.8×+1.0×

Segments

By segment

See full
Integrated Care$409.1M+4.7%
BetterHelp$233.2M-6.7%

FAQ

When did Teladoc Health report Q4 2025 earnings?
Teladoc Health (TDOC) reported Q4 2025 earnings on February 25, 2026 after market close.
What were Teladoc Health's Q4 2025 revenue and EPS?
Teladoc Health reported revenue of $642.3M and eps of $-0.14 for Q4 2025.
Did Teladoc Health beat estimates in Q4 2025?
Revenue beat the consensus estimate of $635.3M by $7.0M. EPS beat the consensus estimate of $-0.19 by $0.05.
How did Teladoc Health's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.3% from $640.5M a year earlier and eps grew 50.0% from $-0.28.
Where can I find Teladoc Health's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001477449-26-000010) and the 10-K periodic report (0001477449-26-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.